Medtronic plcMDT announced that the FDA has approved a new arm indication for the Guardian Sensor 3 continuous glucose monitor (CGM) used with the MiniMed 670G insulin pump. Notably, the Guardian ...

Editor’s Note: A few weeks ago, a Type 1 diabetes patient authored a blog post about why she didn’t want to switch to Medtronic’s MiniMed 670G billed as the industry’s first hybrid closed-loop insulin ...

The FDA has expanded its indication for Medtronic’s Guardian Sensor 3, allowing patients to wear the sensor on their upper arm. The sensor is part of Medtronic’s MiniMed 670G system, and is currently ...

The multi-center study had enrolled 105 participants within the 7-13 years’ age group. The trial had a two-week run-in phase and a study period of three months. Notably, 97% of the participants chose ...

Sales of the company’s MiniMed 670G device, which is the med-tech giant's latest “artificial pancreas” system, partly drove the diabetes division's strong performance. Medtronic reported earnings that ...

Medtronic says real-world data show its MiniMed 670G glucose management system increased time in range for people with diabetes. Medtronic has announced clinical outcomes for the MiniMed 670G system, ...

Closed-loop insulin pump therapy is the most advanced technology available to date for type 1 diabetes. It's "theoretically brilliant, and it's the future," said co-lead investigator Gregory Goodwin, ...

When Medtronic won approval for the MiniMed 670G from the FDA in 2016, it was a big deal. Advertised as “The World’s First Hybrid Closed Loop System,” it is the first commercial product of its kind – ...

The MiniMed 670G system measures glucose levels every 5 minutes and automatically adjusts insulin delivery to avoid highs and lows. The MiniMed 670G hybrid closed looped system (Medtronic), which ...

The MiniMed 670G hybrid closed-loop insulin delivery system (Medtronic) offers the potential for improved blood glucose control for people with type 1 diabetes, but clinicians should anticipate the ...

WASHINGTON--Patients with type 1 diabetes who use Medtronic's MiniMedTM 670G insulin pump system are able to maintain blood glucose levels in the targeted range over 71% of the time, according to a ...

Medtronic plcMDT recently announced FDA approval for its MiniMed 670G system for patients with type 1 diabetes between seven and 13 years of age. Notably, the approval was based on positive data from ...